217 related articles for article (PubMed ID: 31915109)
1. Development and validation of an integrated LC-MS/MS assay for therapeutic drug monitoring of five PARP-inhibitors.
Bruin MAC; de Vries N; Lucas L; Rosing H; Huitema ADR; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Feb; 1138():121925. PubMed ID: 31915109
[TBL] [Abstract][Full Text] [Related]
2. Liquid chromatography-tandem mass spectrometry assay for the quantification of niraparib and its metabolite M1 in human plasma and urine.
van Andel L; Zhang Z; Lu S; Kansra V; Agarwal S; Hughes L; Tibben MM; Gebretensae A; Rosing H; Schellens JHM; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():14-21. PubMed ID: 27898364
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of an LC-MS/MS method with a broad linear dynamic range for the quantification of tivozanib in human and mouse plasma, mouse tissue homogenates, and culture medium.
Bruin MAC; Rosing H; Lucas L; Wang J; Huitema ADR; Schinkel AH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1125():121723. PubMed ID: 31352204
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay quantifying olaparib in human plasma.
Nijenhuis CM; Lucas L; Rosing H; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():121-5. PubMed ID: 24145016
[TBL] [Abstract][Full Text] [Related]
5. UPLC-MS/MS method for the determination of talazoparib in rat plasma and its pharmacokinetic study.
Ye L; Chen J; Li SL; Zhu YL; Xie S; Du X
J Pharm Biomed Anal; 2020 Jan; 177():112850. PubMed ID: 31499430
[TBL] [Abstract][Full Text] [Related]
6. Quantification of cobimetinib, cabozantinib, dabrafenib, niraparib, olaparib, vemurafenib, regorafenib and its metabolite regorafenib M2 in human plasma by UPLC-MS/MS.
Krens SD; van der Meulen E; Jansman FGA; Burger DM; van Erp NP
Biomed Chromatogr; 2020 Mar; 34(3):e4758. PubMed ID: 31758580
[TBL] [Abstract][Full Text] [Related]
7. Determination of fascaplysin in rat plasma with ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS): application to a pharmacokinetic study.
Hu Z; Zhang M; He M; Fang B; Bao X; Yan X; Liang H; Wang H
J Pharm Biomed Anal; 2019 Jul; 171():126-131. PubMed ID: 30986762
[TBL] [Abstract][Full Text] [Related]
8. Liquid chromatography-tandem mass spectrometric assay for the PARP inhibitor rucaparib in plasma.
Sparidans RW; Durmus S; Schinkel AH; Schellens JH; Beijnen JH
J Pharm Biomed Anal; 2014 Jan; 88():626-9. PubMed ID: 24216281
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a sensitive LC-MS/MS method for the assay of four PARP inhibitors in human plasma and its application in ovarian cancer patients.
Wei Y; Liang H; Liu S; Guan S; Ma K; Guan Y; Chen Y; Huang M; Wang X; Lan C
J Pharm Biomed Anal; 2024 Jan; 237():115758. PubMed ID: 37832476
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a sensitive and selective LC-MS/MS method for determination of tacrolimus in oral fluids.
Ghareeb M; Akhlaghi F
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1038():136-141. PubMed ID: 27771258
[TBL] [Abstract][Full Text] [Related]
11. LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring.
Canil G; Orleni M; Posocco B; Gagno S; Bignucolo A; Montico M; Roncato R; Corsetti S; Bartoletti M; Toffoli G
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242766
[TBL] [Abstract][Full Text] [Related]
12. Fast simultaneous LC/MS/MS determination of 10 active compounds in human serum for therapeutic drug monitoring in psychiatric medication.
Sistik P; Urinovska R; Brozmanova H; Kacirova I; Silhan P; Lemr K
Biomed Chromatogr; 2016 Feb; 30(2):217-24. PubMed ID: 26094602
[TBL] [Abstract][Full Text] [Related]
13. Validated assay for the simultaneous determination of cortisol and budesonide in human plasma using ultra high performance liquid chromatography-tandem mass spectrometry.
Szeitz A; Manji J; Riggs KW; Thamboo A; Javer AR
J Pharm Biomed Anal; 2014 Mar; 90():198-206. PubMed ID: 24389462
[TBL] [Abstract][Full Text] [Related]
14. UPLC-MS/MS assay of 21-aminosteroid (lazaroid U74389G) for application in pharmacokinetic study.
Gadgil P; Ibrahim F; Chow DS
J Pharm Biomed Anal; 2016 Apr; 122():90-7. PubMed ID: 26848737
[TBL] [Abstract][Full Text] [Related]
15. LC-MS/MS method for the determination of clodronate in human plasma.
Hasan M; Schumacher G; Seekamp A; Taedken T; Siegmund W; Oswald S
J Pharm Biomed Anal; 2014 Nov; 100():341-347. PubMed ID: 25194348
[TBL] [Abstract][Full Text] [Related]
16. Determination of acamprosate in human plasma by UPLC-MS/MS: Application to therapeutic drug monitoring.
Ozdemir M; Kul A; Ozilhan S; Sagirli O
Biomed Chromatogr; 2020 Nov; 34(11):e4936. PubMed ID: 32602563
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum - Application to therapeutic drug monitoring.
Aghai-Trommeschlaeger F; Zimmermann S; Gesierich A; Kalogirou C; Goebeler ME; Jung P; Pelzer T; Kurlbaum M; Klinker H; Isberner N; Scherf-Clavel O
Clin Biochem; 2022; 105-106():35-43. PubMed ID: 35483452
[TBL] [Abstract][Full Text] [Related]
18. Development of a Novel Analytical Method for Determining Trazodone in Human Plasma by Liquid Chromatography Coupled With Mass Spectrometry Coupled With Automatic 2-Dimensional Liquid Chromatograph-Mass Spectrometer Coupler 9500 and Its Application to Therapeutic Drug Monitoring.
Ding J; Zhang Y; Cui X; Zhao C; Zhang S
Ther Drug Monit; 2022 Jun; 44(3):465-473. PubMed ID: 34469419
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of UHPLC-MS/MS assay for rapid determination of a carvone Schiff base of isoniazid (CSB-INH) in rat plasma: application to pharmacokinetic study.
Iqbal M; Bhat MA; Shakeel F
Biomed Chromatogr; 2015 Jun; 29(6):876-82. PubMed ID: 25378280
[TBL] [Abstract][Full Text] [Related]
20. Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantification of Olorofim (F901318), a Novel Antifungal Drug, in Human Plasma and Serum.
Müller C; Fietz C; Koehler P; Sibley G; Nforbugwe ACA; Streichert T; Wiesen MHJ
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
